Outcomes, preferences for resuscitation, and physician-patient communication among patients with metastatic colorectal cancer
Paul Haidet(Department of Public Health), Russell S. Phillips(University of California Davis Medical Center), Joanne Lynn(George Washington University), Peter S. Kussin(Duke Medical Center), Neil S. Wenger(UCLA Health), Douglas J. Reding(Ascension), Jane C. Weeks(King Edward Memorial Hospital), Roger B. Davis(Beth Israel Deaconess Medical Center), Mary Beth Hamel(Hadassah Medical Center), Alfred F. Connors(University of Virginia)
Cited by 139
Related Papers
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
|BMJ|2008|1.2k
Patients' Expectations about Effects of Chemotherapy for Advanced Cancer
|New England Journal of Medicine|2012|1.1k
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
|JNCI Journal of the National Cancer Institute|2012|1.1k
Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
|Controlled Clinical Trials|2000|1k